Katholische Kliniken Ruhrhalbinsel GmbH

Essen 45257

0 studies enrolling now · 3 studies all time

What they study most

Crohn Disease, Non Alcoholic Steatohepatitis (NASH)

Studies at this site

• Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment — Stopped early
• Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease — Stopped early
• A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease — Withdrawn before enrolling